Biohacking Market Size, Share & Trends Analysis Report By Product, By Application (Synthetic Biology, Drug Testing), By End-use (Hospitals & Clinics, Pharma & Biotech Companies), By Region, And Segment Forecasts, 2024

Description

Biohacking Market Growth & Trends:

The global biohacking market size is anticipated to reach USD 67.86 billion by 2030, registering a CAGR of 18.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Various initiatives by market players and rising funds for biohacking are the major factors fueling the market growth. The adoption of biohacking practices is growing due to their potential applications in decreasing the risk of developing a disease, especially genetically associated diseases, helping an individual to achieve mental, physical, or emotional changes, such as weight loss or reducing depression symptoms; and optimize general functions of the body, such as blood pressure.

The global market has been significantly affected by the COVID-19 pandemic. Some of the major impacts of COVID-19 on the market include supply chain disruptions, a decline in sales, and low demand. However, biohackers in the industry are investing in some research activities for the development of COVID-19 vaccines as well as test kits. This neutralized the market growth in 2020. For the purchase of equipment and materials, biohackers require basic funding. Other than crowdfunding, most of the activities at these labs are self-funded through membership and workshop fees. Furthermore, private donations are also used for raising money.

Oura Health, manufacturer of the Oura ring, a sleep-improvement and sleep tracking platform, raised USD 20 million in Series B funding led by MSD Capital in December 2018. The global market is fairly competitive. Most of the market players have undertaken strategies, such as new product launches, acquisitions, and partnerships, to gain a competitive edge over each other. For instance, in September 2020, Apple Inc. partnered with the government of Singapore for launching a national health initiative using Apple Watch. With this, the country made an effort to leverage technology for delivering advanced health benefits to its citizens.

Biohacking Market Report Highlights:

The wearables segment accounted for a share of 29.9% in 2023. Current developments in this market mainly focus on technological progress, such as adding additional health functions, incorporating Artificial Intelligence for personalized suggestions, and sending live data to healthcare professionals for prompt interventions and better patient results.
The diagnosis and treatment segment held the largest revenue share of over 32.3% in 2023 due to the high usage of biohacking practices, such as nootropics and wearable technologies, for body enhancement purposes.
The hospitals and clinics segment held the largest share of 40.3% in 2023. The segment growth is credited to the increase in chronic diseases and their treatment.
North America biohacking market dominated the market in 2023 with a market share of 36.7%. This is due to the increasing prevalence of chronic illnesses, increase in the awareness of biohacking, and an aging population in the region.
Asia Pacific Biohacking market is anticipated to witness significant growth in 2023 with a CAGR of 20.6% attributing to the rise in healthcare expenditure that has led to economic growth in the region.

Product Code: GVR-4-68039-479-7

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Biohacking Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Biohacking Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Biohacking Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Biohacking Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Wearables
- 4.3.1. Wearables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.3.1.1. Wearable Neurotech
- 4.3.2. Wearables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.1. Oura ring
- 4.3.3. Wearables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.3.3.1. Muse Headband
- 4.3.4. Wearables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.3.4.1. Others
4.4. Implants
- 4.4.1. Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.4.1.1. Blood test Implants
- 4.4.2. Wearables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.4.2.1. Circadia Implants
- 4.4.3. Wearables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.4.3.1. NFC and RFID tags
- 4.4.4. Wearables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.4.4.1. Others
4.5. Gene Modification Kits
- 4.5.1. Gene Modification Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Smart Drugs
- 4.6.1. Smart Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Supplements
- 4.7.1. Supplements Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Mobile Apps
- 4.8.1. Mobile Apps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9. Others
- 4.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Biohacking Market: Application Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Biohacking Market: Application Movement Analysis, 2023 & 2030 (USD Million)
5.3. Synthetic Biology
- 5.3.1. Synthetic Biology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Genetic Engineering
- 5.4.1. Genetic Engineering Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Forensic Science
- 5.5.1. Forensic Science Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Diagnosis & Treatment
- 5.6.1. Diagnosis & Treatment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Drug Testing
- 5.7.1. Drug Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Biohacking Market: Regional Estimates & Trend Analysis

6.1. Biohacking Market Share, By Region, 2023 & 2030 (USD Million)
6.2. North America
- 6.2.1. North America Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.2. U.S.
  - 6.2.2.1. U.S. Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.3. Canada
  - 6.2.3.1. Canada Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.4. Mexico
  - 6.2.4.1. Mexico Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
- 6.3.1. Europe Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2. UK
  - 6.3.2.1. UK Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.3. Germany
  - 6.3.3.1. Germany Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.4. France
  - 6.3.4.1. France Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.5. Italy
  - 6.3.5.1. Italy Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.6. Spain
  - 6.3.6.1. Spain Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.7. Denmark
  - 6.3.7.1. Denmark Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.8. Sweden
  - 6.3.8.1. Sweden Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.9. Norway
  - 6.3.9.1. Norway Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
- 6.4.1. Asia Pacific Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.2. Japan
  - 6.4.2.1. Japan Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.3. China
  - 6.4.3.1. China Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.4. India
  - 6.4.4.1. India Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.5. Australia
  - 6.4.5.1. Australia Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.6. South Korea
  - 6.4.6.1. South Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.7. Thailand
  - 6.4.7.1. Thailand Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
- 6.5.1. Latin America Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.2. Brazil
  - 6.5.2.1. Brazil Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.3. Argentina
  - 6.5.3.1. Argentina Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East and Africa
- 6.6.1. Middle East and Africa Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.2. South Africa
  - 6.6.2.1. South Africa Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.3. Saudi Arabia
  - 6.6.3.1. Saudi Arabia Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.4. UAE
  - 6.6.4.1. UAE Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.5. Kuwait
  - 6.6.5.1. UAE Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
- 7.4.1. Apple Inc.
  - 7.4.1.1. Participant's Overview
  - 7.4.1.2. Financial Performance
  - 7.4.1.3. Product Benchmarking
  - 7.4.1.4. Recent Developments/ Strategic Initiatives
- 7.4.2. THE ODIN
  - 7.4.2.1. Participant's Overview
  - 7.4.2.2. Financial Performance
  - 7.4.2.3. Product Benchmarking
  - 7.4.2.4. Recent Developments/ Strategic Initiatives
- 7.4.3. Thync Inc.
  - 7.4.3.1. Participant's Overview
  - 7.4.3.2. Financial Performance
  - 7.4.3.3. Product Benchmarking
  - 7.4.3.4. Recent Developments/ Strategic Initiatives
- 7.4.4. Fitbit, Inc.
  - 7.4.4.1. Participant's Overview
  - 7.4.4.2. Financial Performance
  - 7.4.4.3. Product Benchmarking
  - 7.4.4.4. Recent Developments/ Strategic Initiatives
- 7.4.5. Moodmetric
  - 7.4.5.1. Participant's Overview
  - 7.4.5.2. Financial Performance
  - 7.4.5.3. Product Benchmarking
  - 7.4.5.4. Recent Developments/ Strategic Initiatives
- 7.4.6. HVMN Inc.
  - 7.4.6.1. Participant's Overview
  - 7.4.6.2. Financial Performance
  - 7.4.6.3. Product Benchmarking
  - 7.4.6.4. Recent Developments/ Strategic Initiatives
- 7.4.7. Muse (Interaxon Inc.)
  - 7.4.7.1. Participant's Overview
  - 7.4.7.2. Financial Performance
  - 7.4.7.3. Product Benchmarking
  - 7.4.7.4. Recent Developments/ Strategic Initiatives
- 7.4.8. Thriveport, LLC
  - 7.4.8.1. Participant's Overview
  - 7.4.8.2. Financial Performance
  - 7.4.8.3. Product Benchmarking
  - 7.4.8.4. Recent Developments/ Strategic Initiatives
- 7.4.9. TrackMyStack
  - 7.4.9.1. Participant's Overview
  - 7.4.9.2. Financial Performance
  - 7.4.9.3. Product Benchmarking
  - 7.4.9.4. Recent Developments/ Strategic Initiatives
- 7.4.10. OsteoStrong
  - 7.4.10.1. Participant's Overview
  - 7.4.10.2. Financial Performance
  - 7.4.10.3. Product Benchmarking
  - 7.4.10.4. Recent Developments/ Strategic Initiative

Biohacking Market Size, Share & Trends Analysis Report By Product, By Application (Synthetic Biology, Drug Testing), By End-use (Hospitals & Clinics, Pharma & Biotech Companies), By Region, And Segment Forecasts, 2024 - 2030